ACHV Achieve Life Sciences

Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.

$6.85  -0.12 (-1.72%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/12/1995
Outstanding shares:  9,453,542
Average volume:  58,446
Market cap:   $65,891,188
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    004468500
ISIN:        US0044685008
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.87
PS ratio:   0.00
Return on equity:   -88.54%
Net income %:   0.00%